| 前收市價 | 3.6000 |
| 開市 | 3.6000 |
| 買盤 | 1.6000 |
| 賣出價 | 5.5000 |
| 拍板 | 17.50 |
| 到期日 | 2024-10-18 |
| 今日波幅 | 3.6000 - 3.6000 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 9 |
Insider MonkeyKiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript
Kiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA) Q1 2024 Earnings Call Transcript April 23, 2024 Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14. KNSA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]
ZacksKiniksa Pharmaceuticals, Ltd. (KNSA) Reports Q1 Loss, Tops Revenue Estimates
Kiniksa Pharmaceuticals (KNSA) delivered earnings and revenue surprises of -78.57% and 4.05%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksArcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why
Arcturus' (ARCT) steady progress with its product candidate, ARCT-032, for the treatment of cystic fibrosis is encouraging.
